Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America guideline committee

Journal of Cardiac Failure

Volumn 18, Issue 2, 2012, Pages 94-106

  Stevenson, William G ^a   Hernandez, Adrian F ^b   Carson, Peter E ^c   Fang, James C ^d   Katz, Stuart D ^e   Spertus, John A ^f   Sweitzer, Nancy K ^g   Tang, W H Wilson ^h   Albert, Nancy M ^h   Butler, Javed ⁱ   Westlake Canary, Cheryl A ^j   Collins, Sean P ^k   Colvin Adams, Monica ^l   Ezekowitz, Justin A ^m   Givertz, Michael M ^a   Hershberger, Ray E ⁿ   Rogers, Joseph G ^b   Teerlink, John R ^o   Walsh, Mary N ^p   Stough, Wendy Gattis ^q   Starling, Randall C ^h   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j AZUSA PACIFIC UNIVERSITY   (United States)

^k VANDERBILT UNIVERSITY   (United States)

^l UNIVERSITY OF MINNESOTA   (United States)

^m UNIVERSITY OF ALBERTA   (Canada)

ⁿ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p Care Group   (United States)

^q CAMPBELL UNIVERSITY   (United States)

more..

Author keywords

cardiac resynchronization therapy; guidelines; Heart failure

Indexed keywords

ADVISORY COMMITTEE; ARTERY DISSECTION; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; COMPLETE HEART BLOCK; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART TAMPONADE; HEART VENTRICLE REMODELING; HEMATOMA; HOSPITALIZATION; HUMAN; HYPOTENSION; INFECTION; LUNG EDEMA; MEDICAL SOCIETY; META ANALYSIS; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PERICARDIAL EFFUSION; PNEUMOTHORAX; PRACTICE GUIDELINE; PRIORITY JOURNAL; QRS COMPLEX; QUALITY ADJUSTED LIFE YEAR; REVIEW; SINUS RHYTHM; SYSTOLIC DYSFUNCTION; WESTERN HEMISPHERE;

CARDIAC PACING, ARTIFICIAL; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGY; HEART FAILURE; HUMANS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84856457010     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.12.004     Document Type: Review

References (62)

1. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853 (Pubitemid 34603028)
2. J.B. Young, W.T. Abraham, A.L. Smith, A.R. Leon, R. Lieberman, and B. Wilkoff Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2003 2685 2694 (Pubitemid 37430139)
3. M.G. Sutton, T. Plappert, K.E. Hilpisch, W.T. Abraham, D.L. Hayes, and E. Chinchoy Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Circulation 113 2006 266 272
4. S.L. Higgins, J.D. Hummel, I.K. Niazi, M.C. Giudici, S.J. Worley, and L.A. Saxon Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias J Am Coll Cardiol 42 2003 1454 1459 (Pubitemid 37267289)
5. A. Auricchio, C. Stellbrink, S. Sack, M. Block, J. Vogt, and P. Bakker Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 2002 2026 2033 (Pubitemid 34628286)
6. S. Cazeau, C. Leclercq, T. Lavergne, S. Walker, C. Varma, and C. Linde Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880 (Pubitemid 32224395)
7. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, and L. Kappenberger The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
8. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and M.T. De Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
9. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
10. K. Dickstein, P.E. Vardas, A. Auricchio, J.C. Daubert, C. Linde, and J. McMurray 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
11. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
12. J. Lindenfeld, N.M. Albert, J.P. Boehmer, S.P. Collins, J.A. Ezekowitz, and M.M. Givertz HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 e194
13. C. Linde, W.T. Abraham, M.R. Gold, S.M. St John, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
14. A.S. Tang, G.A. Wells, M. Talajic, M.O. Arnold, R. Sheldon, and S. Connolly Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
15. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, and J.P. Daubert Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
16. D. Farwell, N.R. Patel, A. Hall, S. Ralph, and A.N. Sulke How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 21 2000 1246 1250 (Pubitemid 30487772)
17. H.J. Shenkman, V. Pampati, A.K. Khandelwal, J. McKinnon, D. Nori, and S. Kaatz Congestive heart failure and QRS duration: establishing prognosis study Chest 122 2002 528 534 (Pubitemid 35002131)
18. G.C. Fonarow, N.M. Albert, A.B. Curtis, W.G. Stough, M. Gheorghiade, and J.T. Heywood Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
19. F.A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, and D.M. Dryden Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review JAMA 297 2007 2502 2514 (Pubitemid 46953404)
20. C. Daubert, M.R. Gold, W.T. Abraham, S. Ghio, C. Hassager, and G. Goode Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial J Am Coll Cardiol 54 2009 1837 1846
21. J.F. Beshai, R.A. Grimm, S.F. Nagueh, J.H. Baker, S.L. Beau, and S.M. Greenberg Cardiac-resynchronization therapy in heart failure with narrow QRS complexes N Engl J Med 357 2007 2461 2471 (Pubitemid 350272785)
22. T.H. Marwick, and R.C. Starling The riddle of determining cardiac resynchronization therapy response a physiologic approach to dyssynchrony therapy J Am Coll Cardiol 52 2008 1410 1412
23. J. Holzmeister, D. Hurlimann, J. Steffel, and F. Ruschitzka Cardiac resynchronization therapy in patients with a narrow QRS Curr Heart Fail Rep 6 2009 49 56
24. Echocardiography-Guided Cardiac Resynchronization Therapy (EchoCRT). ClinicalTrials.gov identifier: NCT00683696.
25. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, and L. Kappenberger Longer-term effects of cardiac resynchronization therapy on mortality in heart failure (the Cardiac Resynchronization-Heart Failure [CARE-HF] trial extension phase) Eur Heart J 27 2006 1928 1932 (Pubitemid 44297365)
26. I. Goldenberg, W.J. Hall, C.A. Beck, A.J. Moss, A. Barsheshet, and S. McNitt Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) J Am Coll Cardiol 58 2011 729 737
27. G. Wells, R. Parkash, J.S. Healey, M. Talajic, J.M. Arnold, and S. Sullivan Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials CMAJ 183 2011 421 429
28. N.S. Al-Majed, F.A. McAlister, J.A. Bakal, and J.A. Ezekowitz Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure Ann Intern Med 154 2011 401 412
29. I. Sipahi, T.P. Carrigan, D.Y. Rowland, B.S. Stambler, and J.C. Fang Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials Arch Intern Med 171 2011 1454 1462
30. D.B. Kramer, and M.E. Josephson Three questions for evidence-based cardiac electrophysiology Circ Cardiovasc Qual Outcomes 3 2010 704 709
31. W.H. Tang, and G.S. Francis Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note Circulation 123 2011 203 208
32. C.R. Reynolds, and M.R. Gold Cardiac resynchronization therapy for mild heart failure: the time has come Circulation 123 2011 195 202
33. S.H. Kubo, S. Schulman, R.C. Starling, M. Jessup, D. Wentworth, and D. Burkhoff Development and validation of a patient questionnaire to determine New York Heart Association classification J Card Fail 10 2004 228 235 (Pubitemid 38869464)
34. C.P. Green, C.B. Porter, D.R. Bresnahan, and J.A. Spertus Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure J Am Coll Cardiol 35 2000 1245 1255 (Pubitemid 30206900)
35. T.S. Rector, S.H. Kubo, and J.N. Cohn Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response to enalapril or placebo Am J Cardiol 71 1993 1106 1107 (Pubitemid 23126823)
36. S.L. Normand, T.S. Rector, J.D. Neaton, I.L. Pina, R.M. Lazar, and S.E. Proestel Clinical and analytical considerations in the study of health status in device trials for heart failure J Card Fail 11 2005 396 403
37. F.W. Prinzen, and A. Auricchio Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is not useful before cardiac resynchronization therapy if QRS duration is available Circ Cardiovasc Imaging 1 2008 70 77
38. J. Abraham, and T.P. Abraham Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available Circ Cardiovasc Imaging 1 2008 79 84
39. E.S. Chung, A.R. Leon, L. Tavazzi, J.P. Sun, P. Nihoyannopoulos, and J. Merlino Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 2008 2608 2616
40. W. Zareba, H. Klein, I. Cygankiewicz, W.J. Hall, S. McNitt, and M. Brown Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Circulation 123 2011 1061 1072
41. A. Arshad, A.J. Moss, E. Foster, L. Padeletti, A. Barsheshet, and I. Goldenberg Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial J Am Coll Cardiol 57 2011 813 820
42. J.P. Singh, D. Fan, E.K. Heist, C.R. Alabiad, C. Taub, and V. Reddy Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy Heart Rhythm 3 2006 1285 1292 (Pubitemid 44615674)
43. J.P. Singh, H.U. Klein, D.T. Huang, S. Reek, M. Kuniss, and A. Quesada Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) trial Circulation 123 2011 1159 1166
44. A.L. Miller, D.B. Kramer, E.F. Lewis, B. Koplan, L.M. Epstein, and U. Tedrow Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach Pacing Clin Electrophysiol 34 2011 490 500
45. Brignole M, Botto G, Mont L. Cardiac resynchronization therapy in patients undergoing AV junction ablation for permanent atrial fibrillation: a randomized trial [abstract]. Heart Rhythm Society Scientific Sessions, May 5, 2011, San Francisco, California. LB-05.
46. J. Gorcsan III Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy Circulation 123 2011 10 12
47. K.A. Ellenbogen, M.R. Gold, T.E. Meyer, I.F. Fernndez Lozano, S. Mittal, and A.D. Waggoner Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy Circulation 122 2010 2660 2668
48. W. Mullens, R.A. Grimm, T. Verga, T. Dresing, R.C. Starling, and B.L. Wilkoff Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program J Am Coll Cardiol 53 2009 765 773
49. C. Adlbrecht, M. Hulsmann, M. Gwechenberger, G. Strunk, C. Khazen, and F. Wiesbauer Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment Eur J Clin Invest 39 2009 1073 1081
50. A. Cheng, Y. Wang, J.P. Curtis, and P.D. Varosy Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry J Am Coll Cardiol 56 2010 1651 1656
51. D.E. Haines, Y. Wang, and J. Curtis Implantable cardioverter- defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation Circulation 123 2011 2069 2076
52. J.E. Poole, M.J. Gleva, T. Mela, M.K. Chung, D.Z. Uslan, and R. Borge Complication rates associated with pacemaker or implantable cardioverter- defibrillator generator replacements and upgrade procedures: results from the REPLACE registry Circulation 122 2010 1553 1561
53. C. Linde, S. Mealing, N. Hawkins, J. Eaton, B. Brown, and J.C. Daubert Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Eur Heart J 32 2011 1631 1639
54. A.M. Feldman, L.G. de, M.R. Bristow, L.A. Saxon, M.T. De, and D.A. Kass Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial J Am Coll Cardiol 46 2005 2311 2321 (Pubitemid 41785503)
55. M.J. Calvert, N. Freemantle, G. Yao, J.G. Cleland, L. Billingham, and J.C. Daubert Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial Eur Heart J 26 2005 2681 2688 (Pubitemid 41746691)
56. M. Jessup MADIT-CRT - breathtaking or time to catch our breath? N Engl J Med 361 2009 1394 1396
57. D.M. Kent, P.M. Rothwell, J.P. Ioannidis, D.G. Altman, and R.A. Hayward Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal Trials 11 2010 85
58. N. Bogale, K. Witte, S. Priori, J. Cleland, A. Auricchio, and F. Gadler The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades Eur J Heart Fail 13 2011 974 983
59. A.D. Krahn, D.S. Lee, D. Birnie, J.S. Healey, E. Crystal, and P. Dorian Predictors of short-term complications after implantable cardioverter- defibrillator replacement: results from the Ontario ICD Database Circ Arrhythm Electrophysiol 4 2011 136 142
60. M. Landolina, M. Gasparini, M. Lunati, S. Iacopino, G. Boriani, and C. Bonanno Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database Circulation 123 2011 2526 2535
61. J.A. Bennett, B. Riegel, V. Bittner, and J. Nichols Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease Heart Lung 31 2002 262 270 (Pubitemid 34774976)
62. C. Raphael, C. Briscoe, J. Davies, W.Z. Ian, C. Manisty, and R. Sutton Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure Heart 93 2007 476 482 (Pubitemid 46631515)